# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Acute myeloid leukemia

Acute Non Lymphoblastic Leukemia
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 51-60 of 671 results.
Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy
Status: Recruiting
Last Changed: Mar 04, 2019
First Received: Feb 15, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): mitoxantrone + etoposide + gemtuzumab ozogamicin
Locations: UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Mar 05, 2020
First Received: Apr 22, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): Atezolizumab, Hu5F9-G4
Locations: UC Davis Comprehensive Cancer Center, Sacramento, California, United States
Yale, New Haven, Connecticut, United States
Columbia University, New York, New York, United States
MD Anderson Cancer Center, Houston, Texas, United States
Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)
Status: Recruiting
Last Changed: Oct 18, 2019
First Received: Oct 06, 2017
Disease(s): Acute Myeloid Leukemia
Intervention(s): Onvansertib, Cytarabine, Decitabine
Locations: University of California Los Angeles, Los Angeles, California, United States
Yale University, New Haven, Connecticut, United States
University of Kansas Cancer Center, Westwood, Kansas, United States
Allina Health Virginia Piper Cancer Institute, Minneapolis, Minnesota, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
... and 5 other locations.
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM43239 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Feb 25, 2019
First Received: Feb 22, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): HM43239
Locations: Memorial Sloan Kettering Cancer Center, New York, New York, United States
MD Anderson Cancer Center, Houston, Texas, United States
Seoul National University Hospital, Seoul, Korea, Republic of
Asan Medical Center, Seoul, Korea, Republic of
Samsung Medical Center, Seoul, Korea, Republic of
... and 1 other locations.
Study of AMG 673 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Nov 20, 2019
First Received: Jul 21, 2017
Disease(s): Acute Myeloid Leukemia
Intervention(s): AMG 673
Locations: Research Site, Birmingham, Alabama, United States
Research Site, Duarte, California, United States
Research Site, Houston, Texas, United States
Research Site, Seattle, Washington, United States
Research Site, Melbourne, Victoria, Australia
... and 3 other locations.
Ph I Study of Alvocidib and Cytarabine/Daunorubicin (7+3) in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML).
Status: Recruiting
Last Changed: Mar 12, 2020
First Received: Oct 02, 2017
Disease(s): Acute Myeloid Leukemia
Intervention(s): Alvocidib, Cytarabine, Daunorubicin
Locations: Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Columbia University, New York, New York, United States
University of North Carolina, Chapel Hill, North Carolina, United States
A Phase 1b Master Trial to Investigate CPX-351 in Subjects With Previously Untreated Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Mar 19, 2020
First Received: Sep 03, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): CPX-351, Venetoclax, Midostaurin, Enasidenib
Locations: City of Hope National Medical Center, Duarte, California, United States
Stanford University School of Medicine- Standford Cancer Institute, Palo Alto, California, United States
A Clinical Trial to Assess the Efficacy and Safety of the Combination of a Drug Call Quizartinib With Chemotherapy (FLAG-IDA) in Patients With Acute Myeloid Leukemia That Has Not Responded to the First Treatment or That Has Returned After the First Treatment
Status: Recruiting
Last Changed: Jan 06, 2020
First Received: Oct 02, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): Quizartinib, Fludarabine, Cytarabine, Idarubicin, glycosylated G-CSF
Locations: Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
Instituto Português de Oncologia do Porto, Porto, Portugal
Hospital General Universitario de Alicante, Alicante, Spain
Complexo Hospitalario Universitario A Coruña, Coruña, Spain
Hospital San Pedro de Alcántara, Cáceres, Spain
... and 9 other locations.
Treatment of Older Adult Acute Myeloid Leukemia Patients Aged 55 to 65 Years
Status: Recruiting
Last Changed: Oct 07, 2016
First Received: May 04, 2015
Disease(s): Acute Myeloid Leukemia
Intervention(s): Daunorubicin, Cytarabine
Locations: Treatment and Diagnosis Center of Leukemia, Tianjin, Tianjin, China
A Study of Indoximod in Combination With (7+3) Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Apr 19, 2019
First Received: Jul 18, 2016
Disease(s): Acute Myeloid Leukemia
Intervention(s): Idarubicin, Cytarabine, Indoximod Freebase, Indoximod HCL F1, Indoximod HCL F2
Locations: Augusta University, Augusta, Georgia, United States
University of Maryland, Baltimore, Maryland, United States
Johns Hopkins, Baltimore, Maryland, United States